- Home
- TNON vs BRTX Comparison
TNON vs BRTX Comparison
Compare TNON & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNON
- BRTX
- Stock Information
- Founded
- TNON 2012
- BRTX 1997
- Country
- TNON United States
- BRTX United States
- Employees
- TNON N/A
- BRTX N/A
- Industry
- TNON Medical Specialities
- BRTX Managed Health Care
- Sector
- TNON Health Care
- BRTX Health Care
- Exchange
- TNON Nasdaq
- BRTX Nasdaq
- Market Cap
- TNON 11.5M
- BRTX 12.5M
- IPO Year
- TNON 2022
- BRTX N/A
- Fundamental
- Price
- TNON $1.18
- BRTX $1.66
- Analyst Decision
- TNON Strong Buy
- BRTX
- Analyst Count
- TNON 2
- BRTX 0
- Target Price
- TNON $5.50
- BRTX N/A
- AVG Volume (30 Days)
- TNON 158.8K
- BRTX 74.0K
- Earning Date
- TNON 11-12-2025
- BRTX 11-11-2025
- Dividend Yield
- TNON N/A
- BRTX N/A
- EPS Growth
- TNON N/A
- BRTX N/A
- EPS
- TNON N/A
- BRTX N/A
- Revenue
- TNON $2,947,000.00
- BRTX $605,200.00
- Revenue This Year
- TNON $43.52
- BRTX $232.67
- Revenue Next Year
- TNON $82.14
- BRTX $52.92
- P/E Ratio
- TNON N/A
- BRTX N/A
- Revenue Growth
- TNON N/A
- BRTX 247.62
- 52 Week Low
- TNON $0.85
- BRTX $1.19
- 52 Week High
- TNON $5.85
- BRTX $2.55
- Technical
- Relative Strength Index (RSI)
- TNON 46.33
- BRTX 65.28
- Support Level
- TNON $1.15
- BRTX $1.19
- Resistance Level
- TNON $1.25
- BRTX $1.47
- Average True Range (ATR)
- TNON 0.04
- BRTX 0.09
- MACD
- TNON 0.00
- BRTX 0.02
- Stochastic Oscillator
- TNON 30.43
- BRTX 100.00
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.